Depression, Mania, and Thyroid Function: A Story of Intimate Relationships

Biology of Depression: From Novel Insights to Therapeutic Strategies

Volumn , Issue , 2008, Pages 523-537

  Whybrow, Peter C ^a   Bauer, Michael ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Disturbances; London; Mania; Physicians; Thyroid

Indexed keywords

EID: 84890987080     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527619672.ch20     Document Type: Chapter

References (74)

1. Clinical Society of London: Report on myxedema. Trans. Clin. Soc. Lond. (Suppl.) 1888, 21, 18.
2. Whybrow, p. C., Prange Jr., A. j., Treadway, C. R., Mental changes accompanying thyroid gland dysfunction. Arch. Gen. Psychiatry 1969, 20, 48-63.
3. Whybrow, p. C., Bauer, M., Behavioral and psychiatric aspects of thyrotoxicosis. In Braverman, L. E., Utiger, R. D. (Eds.), Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000, 673-638.
4. Whybrow, P. C., Bauer, M., Behavioral and psychiatric aspects of hypothyroidism. In Braverman, L. E., Utiger, R. D. (Eds.), Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000, 837-842.
5. Bauer, M., Szuba, M. p., Whybrow, P. C., Psychiatric and behavioral manifestations of hyper-and hypothyroidism. In Wolkowitz, O. M., Rothschild, T. J. (Eds.), Psychoneuroendocrinology: The Scientific Basis of Clinical Practice. Washington, DC: American Psychiatric Press, 2003, 419-444.
6. Gjessing, R., Disturbances of somatic function in catatonia with a periodic course and their compensation. J. Ment. Sci. 1938, 84, 608-621.
7. Bauer, M., Whybrow, P. C., Thyroid hormone, neural tissue and mood modulation. World J. Biol. Psychiatr. 2001, 2, 57-67.
8. Bauer, M., Whybrow, P. C., Thyroid hormone, brain, and behavior. In Pfaff, D. W., Arnold, A. P., Etgen, A. M., Fahrbach, S. E., Rubin, R. T. (Eds.), Hormones, Brain and Behavior. San Diego: Academic Press, 2002, 238-264.
9. Flach, F. F., Celian, C. I., Rawson, R. W., Treatment of psychiatric disorders with triiodothyronine. Am. J. Psychiatry 1958, 114, 841-842.
10. Wilson, I. C., Prange Jr., A. J., Lara, P. p., L-Triiodothyronine alone and with imipramine in the treatment of depressed women. In Prange Jr., A. J. (Ed.), The Thyroid Axis, Drugs, and Behavior. New York: Raven Press, 1974, 49-62.
11. Prange Jr., A. J., Wilson, I. C., Rabon, A. M., Lipton, M. A., Enhancement of imipramine antidepressant activity by thyroid hormone. Am. J. Psychiatry 1969, 126, 457-469.
12. Altshuler, L., Bauer, M., Frye, M., Gitlin, M., Mintz, j., Szuba, M. p., Leight, K. L., Whybrow, P. C., Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am. J. Psychiatr. 2001, 158, 1617-1622.
13. Aronson, R., Offman, H. j., Joffe, R. T., Naylor, D., Triiodothyronine augmentation in the treatment of refractory depression: a meta-analysis. Arch. Gen. Psychiatry 1996, 53, 842-848.
14. Stancer, H. C., Persad, E., Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Arch. Gen. Psychiatr. 1982, 39, 311-312.
15. Bauer, M. S., Whybrow, P. C., Rapid cycling bipolar affective disorders. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch. Gen. Psychiatr. 1990, 47, 435-440.
16. Baumgartner, A., Bauer, M., Hellweg, R., Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial. Neuropsychopharmacol. 1994, 10, 183-189.
17. Bauer, M., Priebe, S., Berghöfer, A., Bschor, T, Kiesslinger, K., Whybrow, P. C., Subjective response to and tolerability of long-term supraphysio-logical doses of levothyroxine in refractory mood disorders. J. Affect Disord. 2001, 64, 35-42.
18. Bauer, M., Berghöfer, A., Bschor, T., Baumgartner, A., Kiesslinger, U., Hellweg, R., et al., Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders. Neuropsycho-pharmacol. 2002, 27, 620-628.
19. Bauer, M., Adli, M., Bschor, T., Heinz, A., Rasgon, N., Frye, M., et al., Clinical applications of levothyroxine in refractory mood disorders. Clin. Appl. Bipolar Disord. 2003, 2, 49-56.
20. Bauer, M., Hellweg, R., Gräf, K. j., Baumgartner, A., Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacol. 1998, 18, 444-455.
21. Rudas, S., Schmitz, M., Pichler, P., Baumgartner, A., Treatment of refractory chronic depression and dysthymia with high-dose thyroxine. Biol. Psychiatr. 1999, 2, 229-233.
22. Whybrow, P. C., Sex differences in thyroid axis function: relevance to affective disorder and its treatment. Depression 1995, 3, 33-42.
23. Baumgartner, A., Gräf, K. J., Kürten, I., Meinhold, H., The hypothalamic-pituitary-thyroid axis in psychiatric patients and healthy subjects: parts 1-4. Psychiatry Res. 1988, 24, 271-332.
24. Whybrow, P. C., Coppen, A., Prange Jr., A. J., Noguera, R., Bailey, J. E., Thyroid function and the response to liothyronine in depression. Arch. Gen. Psychiatr. 1972, 26, 242-245.
25. Kirkegaard, C., Faber, J., The role of thyroid hormones in depression. Eur.J. Endocrinol. 1998, 138, 1-9.
26. 4 and greater mood instability and depression in lithium-maintained bipolar patients. Am.J. Psychiatr. 1999, 156, 1909-1914.
27. Cole, D. P., Thase, M. E., Mallinger, A. G., Soares, J. C., Futher, J. F., Kupfer, D. J., et al., Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am. J. Psychiatr. 2002, 159, 116-121.
28. Bauer, M. S., Whybrow, P. C., Winokur, A., Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism. Arch. Gen. Psychiatr. 1990, 47, 427-432.
29. Cowdry, R. W., Wehr, T. A., Zis, A. P., Goodwin, F. K., Thyroid abnormalities associated with rapid-cycling bipolar illness. Arch. Gen. Psychiatr. 1983, 40, 414-420.
30. Fazarus, J. H., The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 1998, 8, 909-913.
31. Gyulai, F., Bauer, M., Bauer, M. S., García-España, F., Cnaan, A., Whybrow, P. C., Thyroid hypofunction in patients with rapid cycling bipolar disorder after lithium challenge. Biol. Psychiatry 2003, 53, 899-905.
32. Toft, A. D., Thyroxine therapy. N. Engl. J. Med. 1994, 331, 174-180.
33. Reichlin, S., Utiger, R. D., Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. J. Clin. Endocrinol. Metab. 1967, 27, 251-255.
34. Beierwaltes, W. H., Ruff, G. E., Thyroxin and triiodothyronine in excessive dosage to euthyroid humans. Arch. Intern. Med. 1958, 101, 569-576.
35. Braverman, F. E., Vagenakis, A., Downs, P., Foster, A. E., Sterling, K., Ingbar, S. H., Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man. J. Clin. Invest. 1973, 52, 1010-1017.
36. Cohen 3rd, J. H., Ingbar, S. H., Braverman, F. E., Thyrotoxicosis due to ingestion of excess thyroid hormone. Endocr. Rev. 1989, 10, 113-124.
37. Bauer, M., Fairbanks, F., Berghöfer, A., Hierholzer, J., Bschor, T., Rasgon, N., et al., No evidence of accelerated loss of bone density during maintenance treatment with supraphysiological doses of L-thyroxine in prophylaxis-resistant affective disorders. Manuscript submitted.
38. Gyulai, F., Whybrow, P. C., Jaggi, J., Bauer, M. S., Younkin, S., Rubin, F., et al., Bone mineral density and L-thyroxine treatment in rapidly cycling bipolar disorder. Biol. Psychiatr. 1997, 41, 503-506.
39. Gyulai, F., Bauer, M., Espana-Garcia, F., Hierholzer, J., Baumgartner, A., Whybrow, P. C., Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation. J. Affect Disord. 2001, 66, 185-191.
40. Whybrow, P. C., The therapeutic use of triiodothyronine and high-dose thyroxine in psychiatric disorder. Acta Med. Austriaca 1994, 21, 47-52.
41. Bauer, M., Baur, H., Berghöfer, A., Ströhle, A., Hellweg, R., Müller-Oerlinghausen, B., et al., Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders. J. Affect Disord. 2002, 68, 285-294.
42. Refetoff, S., Resistance to thyroid hormone. In Braverman, F. E., Utiger, R. D. (Eds.), Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000, 1028-1043.
43. Sokoloff, F., Wechsler, R. F., Mangold, R., Balls, K., Kety, S. S., Cerebral blood flow and oxygen consumption in hyperthyroidism before and after treatment. J. Clin. Invest. 1953, 32, 202-208.
44. Sensenbach, W., Madison, F., Eisenberg, S., Ochs, F., The cerebral circulation and metabolism in hyperthyroidism and myxedema. J. Clin. Invest. 1954, 33, 1434-1440.
45. Bauer, M., Marseille, D. M., Geist, C. F., Van Herle, K., Rasgon, N., Martinez, D., et al., Effects of thyroid hormone replacement therapy on regional brain metabolism (abstract). J. Nucl. Med. 2002, 43 (5 Suppl.), 254P.
46. Silverman, D. H. S., Geist, C. F., Van Herle, K., Rasgon, N., Martinez, D., Miller, K. J., Haselrig, T., et al., Abnormal regional brain metabolism in patients with hypothyroidism secondary to Hashimoto's disease (abstract). J. Nucl. Med. 2002, 43 (5 Suppl.), 254P.
47. Calza, F., Aloe, F., Giardino, F., Thyroid hormone-induced plasticity in the adult rat brain. Brain Res. Bull. 1997, 44, 549-557.
48. Constant, E. F., de Volder, A. G., Ivanoiu, A., Bol, A., Fabar, D., Seghers, A., et al., Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study. J. Clin. Endocrinol. Metab. 2001, 86, 3864-3870.
49. Drevets, W. C., Neuroimaging studies of mood disorders. Biol. Psychiatr. 2000, 48, 813-829.
50. Marangell, F. B., Ketter, T. A., George, M. S., Pazzaglia, P. J., Callahan, A. M., Parekh, P., et al., Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. Am. J. Psychiatr. 1997, 154, 224-230.
51. Bauer, M., London, E. D., Rasgon, N., Berman, S. M., Frye, M. A., Altshuler, F., et al., Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in women with bipolar depression. 2004, Manuscript submitted.
52. Drevets, W. C., Price, J. F., Simpson Jr., J. R., Todd, R. D., Reich, T., Vannier, M., et al., Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386, 824-827.
53. Brody, A. F., Barsom, M. W., Bota, R. G., Saxena, S., Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin. Clin. Neuropsychiatr. 2001, 6, 102-112.
54. Ketter, T. A., Kimbrell, T. A., George, M. S., Dunn, R. T., Speer, A. M., Benson, B. E., et al., Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol. Psychiatr. 2001, 49, 97-109.
55. Fechan, R. M., Toni, R., Thyroid hormones in neural tissue. In Pfaff, D. W., Arnold, A. P., Etgen, A. M., Fahrbach, S. E., Rubin, R. T. (Eds.), Hormones, Brain and Behavior. San Diego: Academic Press, 2002, 157-238.
56. Sullivan, G. M., Hatterer, J. A., Herbert, J., Chen, X., Roose, S. P., Attia, E., et al., Low levels of transthyretin in the CSF of depressed patients. Am. J. Psychiatry 1999, 156, 710-715.
57. St Germain, D. F., Galton, V. A., The deiodinase family of selenoproteins. Thyroid 1997, 7, 655-668.
58. Köhrle, J., Thyroid hormone metabolism and action in the brain and pituitary. Acta Med. Austriaca 2000, 27, 1-7.
59. St Germain, D., Regulatory effect of lithium on thyroxine metabolism in murine neural and anterior pituitary tissue. Endocrinology 1987, 120, 1430-1438.
60. Baumgartner, A., Pinna, G., Hiedra, F., Gaio, U., Hessenius, C., Campos-Barros, A., et al., The effects of lithium and carbamazepine on thyroid hormone metabolism in rat brain. Neuropsychopharmacol. 1997, 16, 25-41.
61. Hahn, C. G., Pawlyk, A. C., Whybrow, P. C., Gyulai, L., Tejani-Butt, S. M., Lithium administration affects gene expression of thyroid hormone receptors in rat brain. Life Sci. 1999, 64, 1793-1802.
62. Hahn, C. G., Pawlyk, A. C., Whybrow, P. C., Tejani-Butt, S. M., Differential expression of thyroid hormone receptor isoforms by thyroid hormone and lithium in rat GH3 and B103 cells. Biol. Psychiatr. 1999, 45, 1004-1012.
63. Ruel, j., Faure, R., Dussault, J. H., Regional distribution of nuclear T3 receptors in rat brain and evidence for preferential localization in neurons. J. Endocrinol. Invest. 1985, 8, 343-348.
64. Schwartz, H. L., Oppenheimer, J. H., Nuclear triiodothyronine receptor sites in brain: probable identity with hepatic receptors and regional distribution. Endocrinol. 1978, 103, 267-273.
65. Anderson, G. W., Mariash, C. N., Oppenheimer, J. H., Molecular actions of thyroid hormone. In Braverman, L. E., Utiger, R. D. (Eds.), Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000, 174-195.
66. Baumgartner, A., Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research. Int. J. Neuropsycho-pharmacol. 2000, 3, 149-165.
67. Whybrow, P. C., Prange Jr., A. J., A hypothesis of thyroid-catecholamine-receptor interaction. Arch. Gen. Psychiatr. 1981, 38, 106-113.
68. Henley, W. N., Koehnle, T. j., Thyroid hormones and the treatment of depression: an examination of basic hormonal actions in the mature mammalian brain. Synapse 1997, 27, 36-44.
69. Bauer, M., Heinz, A., Whybrow, P. C., Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol. Psychiatr. 2002, 7, 140-156.
70. Robbins, j., Transthyretin from discovery to now. Clin. Chem. Lab. Med. 2002, 40, 1183-1190.
71. Leonard, J. L., Köhrle, j., Intracellular pathways of iodothyronine metabolism. In Braverman, L. E., Utiger, R. D. (Eds.), Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000, 136-171.
72. Guadano-Ferraz, A., Benavides-Piccione, R., Venero, C., Lancha, C., Vennstrom, B., Sandi, C., et al., Lack of thyroid hormone receptor alpha1 is associated with selective alterations in behavior and hippocampal circuits. Mol. Psychiatry 2003, 8, 30-38.
73. Tinnikov, A., Nordstrom, K., Thoren, p., Kindblom, J. M., Malin, S., Rozell, B., Adams, M., Rajanayagam, O., Pettersson, S., Ohlsson, C., Chatterjee, K., Vennstrom, B., Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. EMBO J. 2002, 21, 5079-5087.
74. American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr. Practice 2002, 8, 457-469.